Last reviewed · How we verify
NCT02550366
Accelerated Contrast-Enhanced High Resolution Whole Heart Cardiac MRI
trial testing MRI Contrast in Cardiac Disease in 44 participants. Terminated before completion.
19 January 2024
Quick facts
| Lead sponsor | University of Minnesota |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 44 |
| Start date | 1 January 2016 |
| Primary completion | 19 January 2024 |
| Estimated completion | 19 January 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MRI Contrast — full drug profile →
Conditions studied
- Cardiac Disease — all drugs for Cardiac Disease →
Sponsor
University of Minnesota
Who can join
Adults 18 to 80, any sex, with Cardiac Disease. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Coronary artery disease (CAD) is the leading cause of death in the United States. Cardiac MRI is a non-invasive non-ionizing technique for a comprehensive cardiac exam, which can be used in the diagnosis of CAD. In this work, the investigators will develop and validate techniques for accelerated cardiac MRI, offering better volumetric coverage of the heart, improved contrast, and superior spatial and temporal resolutions.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02550366
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MRI Contrast
Trials testing the same drug.
- NCT07007208 — Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk · Phase 2 · not yet recruiting
- NCT07424027 — Central Vein Sign in Multiple Sclerosis Extension Study · NA · recruiting
- NCT06743347 — Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study · NA · completed
- NCT06617624 — Magnetic Resonance Imaging Development for High Resolution Atrial Structural and Functional Characterization · not yet recruiting
Other recruiting trials for Cardiac Disease
Currently open trials in the same condition.
- NCT07532174 — Efferon LPS Hemoadsorption in Cardiac Surgery Patients · NA · recruiting
- NCT06294119 — Multivariate Approach to the Numerical Assessment of Cortical - Autonomic - VAscular Dynamic Interplay · NA · recruiting
- NCT07274436 — The Clinical Value of Deep Learning-Based Reconstruction Techniques in Cardiac MRI Scanning · recruiting
- NCT07217392 — Left Bundle Branch Area Pacing (LBBAP) PMCF Study · NA · recruiting
- NCT05877755 — Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging · NA · recruiting
Other University of Minnesota trials
Trials by the same sponsor.
- NCT02421497 — MRI Technical Development and Applications in Kidney Disease · not yet recruiting
- NCT04100109 — Evaluating the Metabolic Effects of Polylactose: A Novel Prebiotic · NA · withdrawn
- NCT05454306 — Anser Clavicle Pin for Surgical Management of Midshaft Clavicle Fractures · NA · withdrawn
- NCT03192007 — Multi-Parametric MRI for Renal Transplantation · not yet recruiting
- NCT04940533 — Pharmacokinetics of CFTR Modulators in Pregnant Individuals and in Postpartum Breastfeeding Mothers · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02550366 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Minnesota
- Last refreshed: 23 January 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02550366.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing